INTRODUCTION
In 1971 Cerami and Manning (1) reported that cyanate (NCO) 1 at a concentration of 0.014.10 M inReceived for publication 18 June 1973 and in revised form 14 August 1973. 1Abbreviations used in this paper: CP, carbamyl phoshibits the in vitro sickling of red cells from patients with sickle cell anemia (Hb SS). In a subsequent publication, Gillette, Manning, and Cerami (2) reported that Hb SS red cells, incubated in 0.05 M sodium cyanate for 60-90 min at 370C, had an increased lifespan in vivo compared with a previous measurement of red cell life-span with 'Cr in the same patient.
Cyanic acid, the active form of cyanate in solution, carbamylates the a-NH2 groups of proteins.
R-NH2 + HNCO --R-NH-CO-NH2.
(1)
In addition to this reaction, other reactive groups in protein may become carbamylated at higher cyanate concentrations (3) . However, carbamylation of free a-NH2 groups of hemoglobin is irreversible and occurs about 100 times more readily than other carbamylation reactions (4) . At levels of carbamylation of 1-2 NCO residues per hemoglobin molecule the terminal NH2 groups are the main ones involved. Carbamylation of-N-terminal groups, of which there are four per molecule, raises the oxygen affinity (5) , and it appears to be mainly for this reason that sickling is inhibited (6, 7) .
Red cell life-span is variable in sickle cell anemia (8) , and 'Cr is not an ideal isotope as a red cell label because of variable elution (9, 10) . Because of these difficulties in interpreting '1Cr data, and because the with the survival of his untreated cells. As it has been reported that carbamyl phosphate (CP) also inhibits sickling (12) and improves red cell survival (13), we also examined the effect of this reagent on the life span of Hb SS cells. In the course of this investigation it appeared that the mean age of the Hb SS red cells at the time of carbamylation may govern the effect of the drug. Results of an exploration of this phenomenon raise questions about the potential merits of intermittent extracorporeal carbamylation versus carbamylation by daily oral dosage as a means of therpy.
METHODS
Informed consent was obtained from 20 patients with proven sickle cell anemia. They were all in a relatively asymptomatic state at the time of these investigations, and none had been recently transfused. Carbamylation and labeling procedure. 500 ml of venous blood were collected into ACD formula A in plastic blood bags. After the venesection, one isotope of DFP was injected intravenously to label the circulating cells. The bag of blood was then centrifuged, the plasma was carefully removed and discarded, and the semipacked cells separated into two satellite bags so as to obtain roughly equal portions. These bags were then weighed, and calculated volumes of isotonic NCO or CP were added through 0.22-jam Millipore filters so as to obtain concentrations of 0.01, 0.02, or 0.03 M in the red cell mass, assuming complete permeability. Isotopes of DFP were also added in amounts described below. The blood was gently mixed and allowed to stand in a 37'C water bath for 2 h with occasional mixing. After incubation the blood was washed three times with sterile NaCl solution and reinjected into the patient through a blood-giving set.
The recommended methods for radioisotopic erythrocyte survival studies were followed (14) . The ,ug/kg body weight.
Blood samples were obtained, using EDTA as anticoagulant, from the 3rd or 4th day after injection of the labeled cells, for a period of 6-8 wk. The hematocrit and hemoglobin concentration were measured, and the cells were washed three times and then lysed with a few drops of Triton X100. The hemoglobin concentration of this lysate was recorded. For "P counting, 1 ml of hemolysate was pipetted in triplicate onto 3.7-cm diameter Whatman GF/A glass fiber paper circles stuck to 11 Xk inch plain aluminum planchettes with Duco Cement.3 After the blood had dried, it was covered with a thin layer of a 1: 2 dilution of Eukitt' microscopy mounting medium in toluene. Planchettes were counted to 5%o error in an end window Geiger-Muller system with an aluminum filter (33.8 mg/ cm') to screen out radiation from "C and 'H. To count 'H and "C, 0.5 ml of hemolysate was pipetted in triplicate onto suspended filter papers (Whatman no. 43, 5.5-cm circles). When it was dry, each paper was folded inside a fresh filter paper and compressed into pellets weighing approximately 300 mg. The pellets were then combusted in a Packard 305 Tricarb Sample Oxidizer.' The 'HjO condensate was collected into a vial to which Instagel' scintillator was added, and the "CO2 was collected into ethanolamine which was then automatically rinsed into a vial with methanol and Permablend III' scintillator. Both vials were then counted in a Beckman LS 133 liquid scintillation counter (Beckman Instruments, Fullerton, Calif.). Quenching, which was considerable in the "C samples, was calculated by means of an external standard. The counting efficiency averaged 267O for 'H and 60% for "C. When a sample containing only ["P],DFP was combusted no radioactivity was found in either the "C or 'H vials. All samples were counted in triplicate to 2% error, the results were expressed as disintegrations per minute per milliliter of blood (dpm), and correction for background was obtained by counting unlabeled blood processed and burned in a similar fashion. The separation of 'H and "C was complete, but carry over from one sample to the next in the combustion process was about 2%o and was slightly more for 'H than for "C. To minimize this source of error all the pellets from one red cell survival experiment were kept and combusted together, beginning with the weakest.
The dpm for different days were first plotted roughly on semilog paper. When a straight line was seen to fit the points, the regression of the log of the dpm on time was obtained by the method of least squares. respectively, so that:
where M is the modulus of common logarithms (logioe).
In each case, therefore, the slopes of the log regressions were divided by 0.4343 to obtain k. When the data, expressed as per cent of radioactivity on day zero, are plotted on linear coordinates, the tangent to the curve at zero time has a slope equal to k, expressed as a percentage destruction rate (Fig. 1) . The point where this extrapolated tangent cuts the time axis is defined as the MLS (14) (15) (16) (17) . In the tables, MLS is calculated as 1/k. The mean life span is a result of all the factors affecting the survival of the cell (random loss and senescence) and is to be distinguished from the mean potential life span of cells which escape all destructive processes except senescence. The survival of a normal population of red cells labeled with DFP, in a normal individual, is dscribed by a straight line on linear coordinates, which cuts the time axis at 124±7 days (18) . This is the MLS of normal cells, sometimes referred to as the potential life span of the red cell.
Measurement of the degree of carbamylation. In two separate experiments blood in ACD was incubated, as already described, in 0.01, 0.02, and 0.03 M NCO or CP and, after the cells were washed, the degree of N-terminal carbamylation was determined in Peter Gillette's laboratory at The Rockefeller University, New York, by gas chromatography of valine hydantoin formed by treatment of globin with hot acid (19) . The (Table II) showed no appreciable difference in the disappearance of the two labels over this short survival period suggesting, as has been shown by de Furia, Graziano, and Cerami (20) samples were taken. As the difference was small compared with the difference between treated and untreated red cell survival in most of the studies, we feel justified in claiming that it contributed little to this difference.
Effect of different levels of carbamylation in the same patient. The survival of red cells treated with different concentrations of NCO or CP was compared in three patients (Fig. 2) . In each instance the more heavily carbamylated cells survived longer. It was apparent, however, when considering the results of all the experiments, that 0.01 M NCO was as effective in some patients as 0.03 M NCO was in others (Table IV) . Since degree of deoxygenation was not controlled in these experiments and since DPG binding may affect carbamylation (22) (Fig. 4) , there would apparently be 12% of the originally labeled cells still present in the circulation at 120 days, at which point presumably the survival curve would subside to the time axis. The reticulocyte counts in this patient at the time of labeling was 17%. This suggests that some of the cells that were only a few days old at the time of carbamylation might survive for a normal life span, i.e., they would escape the sickling process. The only other event that would affect the rate of destruction would be the onset of premature senescence. If this occurred, possibly due to the effect of carbamylation on the metabolism of the red cells (23, 24) , the function would subside to the time axis before 124 days. In patient W. H., whose red cells, carbamylated with 0.03 M NCO, were followed for 60 days (Table IV) , 17% of the cells were still present at this time on an exponential curve. A longer observation period of the survival of carbamylated, and preferably normal, red cells would be necessary to prove that premature senescence occurs.
The effect of any particular concentration of carbamylating agent was somewhat unpredictable, survival times being better after exposure to 0.01 M NCO in some patients than after exposure to 0.03 M NCO in others. Although we consider it an improbable explanation, for reasons given above, degrees of carbamylation may have varied in these samples. It was noted, however, that on the whole patients with the shortest survival of untreated cells had the greatest increase after carbamylation (Table IV) . Similarly, patients with a milder rate of destruction showed little increase after carbamylation, for example G. between increase in MLS and reticuloc; 0.7414, P = < 0.05). If red cell destruc is determined by an accumulation of le by the effects of the sickle-unsickle seems possible that red cells might ben carbamylation at an early age than lai life span. If so, the younger the mean red cell population treated, the greater effect of protecting them from sickling.
Effect of carbamylation on the sur, cells. To test the above hypothesis we blood from one patient and centrifuged i the less dense and younger cells in th( of the red cell mass. By placing a Peyer surgical clamp across the bag it was possible to separate these red cells. Half the low-density population of cells was carbamylated with 0.03 M NCO and labeled with DFP. The other half was labeled with a second isotope, and the circulating red cell population was labeled in vivo with a third isotope of DFP. Decay curves of all three isotopes of DFP were then followed. The result is shown graphically in Fig. 5 . Unfortunately, the patient developed an intercurrent infection and painful crisis about the 30th day of the survival study, and a steady state with regard to his red cell mass was probably not maintained, since reticulocyte counts and hematocrit both fell. Up to this point, however, the carbamylated, separated population had a greatly decreased rate of removal when compared with the uncarbamylated, but separated, population. The MLS of circulating cells labeled in vivo was only 8.6 days. Extrapolation of the disappearance rate of the uncarbamylated, lowdensity, population shows that less than 0.1% would survive to 124 days whereas, if the carbamylated cells continued to disappear at the rate measured over the first 30 days, 20% would survive to the normal life span. This is an exaggeration of the effect already noted and confirms that carbamylation has a more pronounced effect on the rate of hemolysis when the cell population has been manipulated to remove the ----denser, and probably older and already damaged, red cells. The fact that data for the separated, carbamylated population fit a fairly good line on linear coordinates 100 120 when the last two points are included is probably fortuitous and illustrates the uncertainty in analyzing 0.03 M CP on these curves. As the last two points are probably invalid, top the data are no conclusion can be reached. The same patient who low on a linear nocnlso a erahd h aeptet h e of the labeled has been taking oral cyanate (28 mg/kg body weight) ,) to show that, daily for 3 mo, and whose hemoglobin is carbamylated s (open circles) to the extent of 0.5 mol NCO/mol Hb, now has a red cells would still cell mean life span of 18 days (Fig. 5, insert) (25) , it genated. They were then centrifuged in a cellulose iefit more from nitrate tube at 140,000 g for half an h by a previously ter on in their described technique (26) and the packed-cell column cell age of the cut with a tube slicer into a top, middle, and bottom r would be the fraction. The 14C specific activity of hemoglobin in the washed lysed cells from each fraction was measured.
vival of young The results given in Table V show that specific activity took a unit of was the same throughout the red cell population, sugt to concentrate gesting that the degree of carbamylation is not dee upper portion pendent on cell age. 
DISCUSSION
Our results confirm the findings of Gillette and coworkers (2) that carbamylation of Hb SS red cells improves their in vivo survival. If a method were to be developed whereby the whole red cell mass could be carbamylated in a closed system, a temporary decrease in red cell destruction rate would be achieved. In such a system, carbamyl phosphate might be a better agent than cyanate because of the large amounts of carbamyl phosphatase present in tissues, which can decompose carbamyl phosphate to ammonia and C02 (27-29), thus lessening the need to wash the cells free of cyanate which may be toxic to other tissues. The data presented here, however, suggest that the goals of intermittent extracorporeal carbamylation would be difficult to accomplish.
Even from the appearance of the blood smear in sickle cell anemia it is evident that the red cell population is heterogeneous. In a population of Hb SS erythrocytes the hemoglobin concentration varies considerably from cell to cell (26, 30, 31) , as does the content of Hb F (26, 32) and the number of irreversibly sickled cells (26, 31, 33) . The number of irreversibly sickled cells seen in smears is probably an index of the rate at which they are forming (26) , and it has been shown to correlate with the rate of destruction (33) . A series of sicklingunsickling event are thought to lead to the formation it does not follow that all the circulating cells will be carbamylated to the same extent, but rather that cells which have been circulating for a day or two will have less carbamylation than cells which have been circulating for several weeks. The rate at which newly formed cells become carbamylated to an extent that will protect them from sickling, before they are fatally damaged by sickling, may determine the extent by which the red cell survival can be improved. From the results of our studies it does not seem that carbamylation to the extent of 1 mol NCO/mol Hb will have more than a modest effect on red cell survival, although we cannot predict the increase in red cell survival which would be produced by oral therapy to this mean level of carbamylation. Certainly the hemolytic anemia will not be cured, and we must await further clinical evaluation of this new therapeutic agent to see whether some decrease in the rate of red cell destruction will be accompanied by improvement in the life of the patient.
